boy or girl baby? backstage jobs chicago louise portmanandaust st1300 european economic area 2008 mitsubishi lancer upgrades. class c felony www.soe.
read more »
Add this link to...
Bury
Add to:
| Bookmarks
|
April 23 (Bloomberg) -- Stocks in Europe and Asia gained after Merck KGaA reported profit that topped analysts' estimates and higher metals prices boosted earnings prospects for commodity producers. U.S. index futures increased.
read more »
Add this link to...
Bury
Add to:
| Bookmarks
|
Nereus Pharmaceuticals, Inc., a pioneer in drug discovery from marine microbial sources, announced that enrolment has begun in a phase Ib study evaluating the proteasome inhibitor NPI-0052 in combination with vorinostat (Zolinza, Merck & Co.) in pat
read more »
Add this link to...
Bury
Add to:
| Bookmarks
|
|
|
Merck & Co. reports earnings for the first quarter on Monday. The following is a summary of key developments and analyst opinion related to the period.
read more »
Add this link to...
Bury
Add to:
| Bookmarks
|
Tight cost controls helped Merck and Novartis to report better-than-expected quarterly earnings, while high expenses led to disappointing results from Eli Lilly.
read more »
Add this link to...
Bury
Add to:
| Bookmarks
|
Tight cost controls helped Merck & Co and Swiss drugmaker Novartis AG to better-than-expected quarterly earnings on Monday, while high expenses contributed to disappointing results from Eli Lilly and Co .
read more »
Add this link to...
Bury
Add to:
| Bookmarks
|
WHITEHOUSE STATION, N.J.----Merck & Co., Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended two medicines for marketing approval in the European Union .
read more »
Add this link to...
Bury
Add to:
| Bookmarks
|
The New York Times on Saturday examined how a recent report indicating that Merck used "ghostwriters" to produce medical journal articles in support of the COX-2 inhibitor Vioxx "has galvanized opponents to a federal proposal that would relax some r
read more »
Add this link to...
Bury
Add to:
| Bookmarks
|
|
|
|
|
Le laboratoire pharmaceutique américain Merck annonce un bénéfice net en hausse au titre du premier trimestre et supérieur aux attentes, porté par la progression des ventes de son anti-cholestérol Vytorin et de celles d'autres médicaments.
read more »
Add this link to...
Bury
Add to:
| Bookmarks
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|